180 related articles for article (PubMed ID: 33346795)
1. Assessment of Filled Buprenorphine Prescriptions for Opioid Use Disorder During the Coronavirus Disease 2019 Pandemic.
Nguyen TD; Gupta S; Ziedan E; Simon KI; Alexander GC; Saloner B; Stein BD
JAMA Intern Med; 2021 Apr; 181(4):562-565. PubMed ID: 33346795
[TBL] [Abstract][Full Text] [Related]
2. Concentration of Patient Care Among Buprenorphine-Prescribing Clinicians in the US.
Stein BD; Saloner B; Schuler MS; Gurvey J; Sorbero M; Gordon AJ
JAMA; 2021 Jun; 325(21):2206-2208. PubMed ID: 34061152
[TBL] [Abstract][Full Text] [Related]
3. Datapoints: regional variation in benzodiazepine prescribing for patients on opioid agonist therapy.
Park TW; Bohnert AS; Austin KL; Saitz R; Pizer SD
Psychiatr Serv; 2014 Jan; 65(1):4. PubMed ID: 24382761
[No Abstract] [Full Text] [Related]
4. Early-Career and Graduating Physicians More Likely to Prescribe Buprenorphine.
Peterson LE; Morgan ZJ; Eden AR
J Am Board Fam Med; 2020; 33(1):7-8. PubMed ID: 31907240
[TBL] [Abstract][Full Text] [Related]
5. Growth and Distribution of Buprenorphine-Waivered Providers in the United States, 2007-2017.
McBain RK; Dick A; Sorbero M; Stein BD
Ann Intern Med; 2020 Apr; 172(7):504-506. PubMed ID: 31905379
[No Abstract] [Full Text] [Related]
6. Prescribing of Opioid Analgesics and Buprenorphine for Opioid Use Disorder During the COVID-19 Pandemic.
Currie JM; Schnell MK; Schwandt H; Zhang J
JAMA Netw Open; 2021 Apr; 4(4):e216147. PubMed ID: 33856474
[TBL] [Abstract][Full Text] [Related]
7. Changes in Outpatient Buprenorphine Dispensing During the COVID-19 Pandemic.
Cance JD; Doyle E
JAMA; 2020 Dec; 324(23):2442-2444. PubMed ID: 33320215
[TBL] [Abstract][Full Text] [Related]
8. Barriers and facilitators for emergency department initiation of buprenorphine: A physician survey.
Lowenstein M; Kilaru A; Perrone J; Hemmons J; Abdel-Rahman D; Meisel ZF; Delgado MK
Am J Emerg Med; 2019 Sep; 37(9):1787-1790. PubMed ID: 30803850
[No Abstract] [Full Text] [Related]
9. Changes in Buprenorphine Prescribing in Community Health Centers.
Hartung DM; Voss RW; Bailey SR; Huguet N; Muench J
JAMA Health Forum; 2024 Apr; 5(4):e240634. PubMed ID: 38669032
[TBL] [Abstract][Full Text] [Related]
10. Use of Telemedicine for Buprenorphine Inductions in Patients With Commercial Insurance or Medicare Advantage.
Barsky BA; Busch AB; Patel SY; Mehrotra A; Huskamp HA
JAMA Netw Open; 2022 Jan; 5(1):e2142531. PubMed ID: 34989798
[TBL] [Abstract][Full Text] [Related]
11. Federal Impacts on Buprenorphine Prescribing in Washington State, 2012 to 2022.
Xiong F; Jetson J; Park C; Delcher C
Am J Public Health; 2024 Jul; 114(7):696-704. PubMed ID: 38696736
[No Abstract] [Full Text] [Related]
12. Treatment of Opioid Use Disorder Among Commercially Insured Patients in the Context of the COVID-19 Pandemic.
Huskamp HA; Busch AB; Uscher-Pines L; Barnett ML; Riedel L; Mehrotra A
JAMA; 2020 Dec; 324(23):2440-2442. PubMed ID: 33320214
[TBL] [Abstract][Full Text] [Related]
13. Impact of Medicaid Expansion on Medicaid-covered Utilization of Buprenorphine for Opioid Use Disorder Treatment.
Wen H; Hockenberry JM; Borders TF; Druss BG
Med Care; 2017 Apr; 55(4):336-341. PubMed ID: 28296674
[TBL] [Abstract][Full Text] [Related]
14. Analysis of psychiatrists' prescription of opioid, benzodiazepine, and buprenorphine in Medicare Part D in the United States.
Pan K; Silver S; Davis C
Trends Psychiatry Psychother; 2020; 42(1):48-54. PubMed ID: 32321084
[TBL] [Abstract][Full Text] [Related]
15. Buprenorphine Prescribing Not Contingent on Counseling, Other Services.
Harris E
JAMA; 2023 Jun; 329(22):1908. PubMed ID: 37223956
[No Abstract] [Full Text] [Related]
16. Characteristics and correlates of U.S. clinicians prescribing buprenorphine for opioid use disorder treatment using expanded authorities during the COVID-19 pandemic.
Jones CM; Diallo MM; Vythilingam M; Schier JG; Eisenstat M; Compton WM
Drug Alcohol Depend; 2021 Aug; 225():108783. PubMed ID: 34049102
[TBL] [Abstract][Full Text] [Related]
17. Should we be routinely co-prescribing naloxone for patients on long term opioids?
Prathivadi P; Nielsen S
Med J Aust; 2021 May; 214(9):403-404.e1. PubMed ID: 33895991
[No Abstract] [Full Text] [Related]
18. Steps physicians report taking to reduce diversion of buprenorphine.
Yang A; Arfken CL; Johanson CE
Am J Addict; 2013; 22(3):184-7. PubMed ID: 23617857
[TBL] [Abstract][Full Text] [Related]
19. Patients With Opioid Use Disorder Deserve Trained Providers.
Weimer MB; Tetrault JM; Fiellin DA
Ann Intern Med; 2019 Dec; 171(12):931-932. PubMed ID: 31766053
[No Abstract] [Full Text] [Related]
20. Impact of COVID-19 Related Policy Changes on Buprenorphine Dispensing in Texas.
Thornton JD; Varisco TJ; Bapat SS; Downs CG; Shen C
J Addict Med; 2020 Dec; 14(6):e372-e374. PubMed ID: 33031213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
